Literature DB >> 7635525

Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization.

S Qian1, F Fu, Y Li, L Gao, L Lu, H Noyola, A S Rao, A W Thomson, J J Fung.   

Abstract

Livers but not hearts are accepted spontaneously without immunosuppression when transplanted from B10 (KbAbEbDb) to C3H (KkAkEkDk) mice. Both organs however, undergo accelerated rejection in C3H recipients presensitized with B10 skin grafts. In this study, we have investigated further the role of functional cell-surface major histocompatibility complex (MHC class I or class II molecules in allosensitization. Skin from transgenic MHC class I (b2mmlUncbcr; AbEb) or class II (C2DTM, KbDb) gene 'knockout' mice was grafted onto naive recipients 2-3 weeks prior to whole organ transplantation. When C3H hosts were presensitized with skin from C2DTM (class II deficient) mice, they promptly rejected (within 4 days) subsequently transplanted B10 liver or heart allografts. In contrast, presensitization with skin from b2m (beta 2-m mutant; class I deficient) mice did not significantly affect the survival of either organ graft. Maximal sensitization was established by day 14 after skin grafting and persisted for at least 12 weeks. Splenocytes obtained from C3H mice sensitized with skin from B10, B6 (KbAbEbDb), or C2DTM but not from b2m mice exhibited an H-2b-specific cytolytic response when tested in cell-mediated lymphocytotoxicity assays. Sera from C3H mice sensitized with B10 or b2m skin contained high titres of cytotoxic activity specifically against H-2b class I. Taken together, these observations suggest that in the strain combination studied, MHC class I rather than class II molecules play an important role in allosensitization. The results indicate the potential importance of avoiding transplantation of organs into recipients of secondary grafts from donors that share human leucocyte antigen (HLA) class I antigens with the first donor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635525      PMCID: PMC1384028     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

2.  Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice.

Authors:  M J Grusby; R S Johnson; V E Papaioannou; L H Glimcher
Journal:  Science       Date:  1991-09-20       Impact factor: 47.728

3.  Orthotopic liver transplantation in the mouse.

Authors:  S G Qian; J J Fung; A V Demetris; S T Ildstad; T E Starzl
Journal:  Transplantation       Date:  1991-09       Impact factor: 4.939

4.  Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.

Authors:  B H Koller; P Marrack; J W Kappler; O Smithies
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

5.  Computer algorithm that predicts both acceptable and unacceptable private and public HLA class I antigens in highly sensitized patients.

Authors:  J S Thompson; J E Bryne; H O Hempel; J W Oldfather; W F Green; D O Crowe; F Sanfilippo; J M MacQueen; R N McCalmon; G N Tardiff
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

Review 6.  MHC class I-deficient mice.

Authors:  D H Raulet
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

7.  Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells.

Authors:  M Zijlstra; M Bix; N E Simister; J M Loring; D H Raulet; R Jaenisch
Journal:  Nature       Date:  1990-04-19       Impact factor: 49.962

8.  Differential stimulatory requirements and regulation of naive and primed human lymphocytes.

Authors:  N E Goeken
Journal:  Hum Immunol       Date:  1984-08       Impact factor: 2.850

Review 9.  Laboratory and clinical management of the highly sensitized organ transplant recipient.

Authors:  W E Braun
Journal:  Hum Immunol       Date:  1989-12       Impact factor: 2.850

10.  Skin graft rejection by beta 2-microglobulin-deficient mice.

Authors:  M Zijlstra; H Auchincloss; J M Loring; C M Chase; P S Russell; R Jaenisch
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

View more
  3 in total

1.  Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction.

Authors:  S Qian; L Lu; F Fu; Y Li; W Li; T E Starzl; J J Fung; A W Thomson
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

2.  Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity.

Authors:  S Qian; L Lu; F Fu; W Li; F Pan; R J Steptoe; F G Chambers; T E Starzl; J J Fung; A W Thomson
Journal:  Transplantation       Date:  1998-06-27       Impact factor: 4.939

3.  Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats.

Authors:  N Murase; T E Starzl; M Tanabe; S Fujisaki; H Miyazawa; Q Ye; C P Delaney; J J Fung; A J Demetris
Journal:  Transplantation       Date:  1995-07-27       Impact factor: 4.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.